Male sex is associated with higher mortality among patients with hepatocellular carcinoma
1. In patients with hepatocellular carcinoma, male sex was associated with significantly higher mortality compared to female sex, but the ...
Tag: oncology
Daraxonrasib extends survival in metastatic pancreatic cancer
1. Daraxonrasib is the first-in-class RAS inhibitor approved for metastatic pancreatic adenocarcinoma, addressing a molecular pathway that drives most pancreatic ...
Molecularly guided therapy may improve outcomes in patients with unfavourable cancer of unknown primary compared with standard chemotherapy
1. The use of molecularly guided therapy (MGT) was associated with significantly improved progression-free survival (PFS) compared with standard platinum-based ...
2 Minute Medicine Rewind September 7, 2026
Maternal Body Mass Index, Gestational Weight Gain, and Cardiovascular Disease in Offspring 1. Higher maternal body mass index (BMI) was ...
Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy
1. Cognitive behaviour therapy for insomnia (CBT-I) is more effective in reducing insomnia for women undergoing chemotherapy for breast cancer ...
Tumour microenvironment factors may influence cancer progression and response to tamoxifen (Nolvadex) in patients with estrogen receptor-positive and human epidermal growth factor receptor 2 breast cancer
1. In patients with estrogen receptor (ER)+ and human epidermal growth factor receptor 2 (HER2)- breast cancer, certain tumour microenvironments ...
Younger age and systemic metastases may independently predict survival among patients with choroidal metastases
1. Younger age (<59.6 years) and systemic metastases (>1) were independent predictors of survival among patients with choroidal metastases. Evidence ...
A digital mental health intervention may improve anxiety in breast cancer survivors
1. Among a large cohort of breast cancer survivors, those who participated in digital mental health treatment reported a reduction ...
Enzalutamide (Xtandi) and abiraterone (Zytiga) may have similar effectiveness in metastatic castration-sensitive prostate cancer
1. The use of enzalutamide (Xtandi) and abiraterone (Zytiga) in metastatic castration-sensitive prostate cancer (mCSPC) was associated with similar overall ...
Chemotherapy exposure is independently associated with reduced pain severity in advanced pancreatic cancer
1. Chemotherapy appears to be independently associated with reduced pain severity in advanced pancreatic cancer, reinforcing the importance of routine, ...
